+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dyskinesia Market by Treatment Type (Non-Pharmacological Approaches, Pharmacological Treatments, Surgical Treatments), Dyskinesia Type (Athetosis, Chorea, Dystonia-Related Dyskinesia), Route of Administration, Patient Care Settings - Global Forecast 2025-2030- Product Image
Dyskinesia Market by Treatment Type (Non-Pharmacological Approaches, Pharmacological Treatments, Surgical Treatments), Dyskinesia Type (Athetosis, Chorea, Dystonia-Related Dyskinesia), Route of Administration, Patient Care Settings - Global Forecast 2025-2030- Product Image
Sale

Dyskinesia Market by Treatment Type (Non-Pharmacological Approaches, Pharmacological Treatments, Surgical Treatments), Dyskinesia Type (Athetosis, Chorea, Dystonia-Related Dyskinesia), Route of Administration, Patient Care Settings - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082614
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The dyskinesia market is experiencing accelerated transformation, powered by innovations in neuromodulation, evolving regulatory policies, and rising demand for integrated, patient-centric care strategies. Senior leaders in life sciences and healthcare need actionable insights to navigate technology adoption, regulatory adaptation, and global supply chain considerations in this dynamic space.

Market Snapshot: Dyskinesia Market Growth and Opportunities

The Dyskinesia Market expanded from USD 3.42 billion in 2024 to USD 3.66 billion in 2025. It is projected to sustain growth at a CAGR of 7.30%, reaching USD 5.23 billion by 2030. This trajectory reflects strong momentum in R&D, increased prevalence of neurological disorders, and greater global investment in advanced treatments and digital health platforms.

Scope & Segmentation: Comprehensive Market Coverage

This report delivers a segmented view of the dyskinesia market, emphasizing market intelligence essential for strategic decisions:

  • Treatment Type: Non-pharmacological approaches, pharmacological treatments, and surgical interventions provide diverse clinical options.
  • Dyskinesia Type: Includes athetosis, chorea, dystonia-related manifestations, myoclonic dyskinesia, Parkinson’s dyskinesia, spasmodic torticollis, and tardive dyskinesia.
  • Route of Administration: Solutions span intravenous and infusion-based methods, oral forms, subcutaneous injections, and transdermal applications—each with unique benefits for efficacy and patient compliance.
  • Patient Care Settings: Key environments include home care, hospitals, research institutes, and specialty clinics or rehabilitation centers, supporting both innovative and standard therapies.
  • Geographical Coverage:
    • Americas: United States (including California, Texas, New York, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina
    • Europe, Middle East & Africa: United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland
    • Asia-Pacific: China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan
  • Leading Companies: Includes Abbott Laboratories, AbbVie Inc., Addex Therapeutics Ltd., Bukwang Pharmaceutical Co., Ltd., Medtronic PLC, Neurocrine Biosciences, Inc., Teva Pharmaceutical Industries Ltd., Zydus Lifesciences Limited, and others focused on both pharmacological and device-based solutions.

Dyskinesia Market: Key Takeaways for Decision-Makers

  • Technology integration—such as AI-enabled diagnostics and digital health solutions—is supporting earlier detection, improved patient stratification, and personalized treatment delivery.
  • Patient monitoring and remote therapeutic adjustments are becoming central, as decentralized care models generate high-value datasets for ongoing research and clinical optimization.
  • Organizations are forming strategic alliances and cross-industry consortia, expediting R&D, sharing clinical expertise, and enhancing access to emerging therapies across global markets.
  • Reimbursement landscapes and adaptive regulatory approvals are incentivizing value-based care, favoring treatments that reliably improve patient functionality and operational efficiency.
  • Global market entry strategies require adaptation to diverse healthcare infrastructure, regulatory complexity, and cultural differences across regions.

Tariff Impact on Dyskinesia Supply Chains

Revision of United States trade tariffs in 2025 affected imported pharmaceuticals, devices, and therapeutic materials crucial to dyskinesia care. Industry adaptation involved regional procurement, supply chain relocalization, and joint advocacy for essential product exemptions. Healthcare providers responded by emphasizing value-driven purchasing, cost-optimization, and a shift towards digital outpatient management. These measures collectively strengthen operational agility and supply resilience, helping organizations to mitigate geopolitical and regulatory uncertainties while maintaining patient access to innovative treatment options.

Methodology & Data Sources

This report employs a multi-tiered research approach, combining secondary analyses of academic publications, regulatory filings, and patent data with structured interviews and expert roundtables. Data triangulation and rigorous reviews support robust, actionable insights and validate market findings for accuracy and reliability.

Why This Report Matters for Industry Leaders

  • Enables efficient resource allocation and competitive positioning by mapping the evolving therapeutic landscape and global market segmentation.
  • Supports risk management, from regulatory adaptation to supply chain localization, ensuring readiness for industry and policy disruptions.
  • Delivers critical intelligence to inform partnership strategies, technology assessment, and market entry or expansion across diverse regions.

Conclusion

The dyskinesia market is evolving with new treatment modalities, supply chain adaptations, and collaborative industry models. Strategic agility and data-driven innovation are essential for sustained growth and improved patient outcomes in this dynamic sector.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of wearable sensors and AI analytics for continuous dyskinesia monitoring and management
5.2. Emerging utilization of gene editing and RNA therapies to target underlying dyskinesia pathophysiology
5.3. Expansion of FDA-approved long-acting levodopa formulations to improve symptom control in advanced Parkinson’s dyskinesia
5.4. Increasing investor interest in neuromodulation devices for personalized treatment of refractory dyskinesia symptoms
5.5. Enhanced reimbursement frameworks and value-based contracts accelerating access to innovative dyskinesia therapies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Dyskinesia Market, by Treatment Type
8.1. Introduction
8.2. Non-Pharmacological Approaches
8.2.1. Behavioral Therapy
8.2.2. Physical Therapy & Rehabilitation
8.3. Pharmacological Treatments
8.3.1. Anticholinergics
8.3.2. Dopamine Modulators
8.3.3. GABA Agonists
8.3.4. NMDA Receptor Antagonists
8.3.5. VMAT2 Inhibitors
8.4. Surgical Treatments
8.4.1. Ablative Surgery
8.4.2. Deep Brain Stimulation (DBS)
9. Dyskinesia Market, by Dyskinesia Type
9.1. Introduction
9.2. Athetosis
9.3. Chorea
9.4. Dystonia-Related Dyskinesia
9.5. Myoclonic Dyskinesia
9.6. Parkinson’s Dyskinesia
9.7. Spasmodic Torticollis
9.8. Tardive Dyskinesia
10. Dyskinesia Market, by Route of Administration
10.1. Introduction
10.2. Intravenous (IV) & Infusion-Based
10.3. Oral
10.4. Subcutaneous
10.5. Transdermal
11. Dyskinesia Market, by Patient Care Settings
11.1. Introduction
11.2. Home Care
11.3. Hospitals
11.4. Research Institutes
11.5. Specialty Clinics & Rehabilitation Centers
12. Americas Dyskinesia Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Dyskinesia Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Dyskinesia Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Abbott Laboratories
15.3.2. AbbVie Inc.
15.3.3. Addex Therapeutics Ltd.
15.3.4. Bukwang Pharmaceutical Co., Ltd
15.3.5. Clearmind Medicine Inc.
15.3.6. Ipsen Pharma SAS
15.3.7. IRLAB Therapeutics AB
15.3.8. Luye Pharma Group Ltd.
15.3.9. Medtronic PLC
15.3.10. Melior Pharmaceuticals
15.3.11. Mitsubishi Tanabe Pharma Corporation
15.3.12. Motac France Sarl
15.3.13. Neurocrine Biosciences, Inc.
15.3.14. Neurolixis Inc.
15.3.15. PharmaTher Holdings Ltd.
15.3.16. Prilenia Therapeutics B.V.
15.3.17. ReCode Therapeutics, Inc.
15.3.18. Serina Therapeutics, Inc.
15.3.19. SOM INNOVATION BIOTECH, SA
15.3.20. Supernus Pharmaceuticals, Inc.
15.3.21. Teva Pharmaceutical Industries Ltd.
15.3.22. Toray Industries, Inc.
15.3.23. Vistagen Therapeutics, Inc.
15.3.24. Voyager Therapeutics, Inc.
15.3.25. Zydus Lifesciences Limited
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. DYSKINESIA MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DYSKINESIA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DYSKINESIA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DYSKINESIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS DYSKINESIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS DYSKINESIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES DYSKINESIA MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES DYSKINESIA MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. DYSKINESIA MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. DYSKINESIA MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. DYSKINESIA MARKET: RESEARCHAI
FIGURE 24. DYSKINESIA MARKET: RESEARCHSTATISTICS
FIGURE 25. DYSKINESIA MARKET: RESEARCHCONTACTS
FIGURE 26. DYSKINESIA MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DYSKINESIA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DYSKINESIA MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DYSKINESIA MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DYSKINESIA MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DYSKINESIA MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DYSKINESIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DYSKINESIA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DYSKINESIA MARKET SIZE, BY BEHAVIORAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DYSKINESIA MARKET SIZE, BY BEHAVIORAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DYSKINESIA MARKET SIZE, BY PHYSICAL THERAPY & REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DYSKINESIA MARKET SIZE, BY PHYSICAL THERAPY & REHABILITATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DYSKINESIA MARKET SIZE, BY ANTICHOLINERGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DYSKINESIA MARKET SIZE, BY ANTICHOLINERGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DYSKINESIA MARKET SIZE, BY DOPAMINE MODULATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DYSKINESIA MARKET SIZE, BY DOPAMINE MODULATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DYSKINESIA MARKET SIZE, BY GABA AGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DYSKINESIA MARKET SIZE, BY GABA AGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DYSKINESIA MARKET SIZE, BY NMDA RECEPTOR ANTAGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DYSKINESIA MARKET SIZE, BY NMDA RECEPTOR ANTAGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DYSKINESIA MARKET SIZE, BY VMAT2 INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DYSKINESIA MARKET SIZE, BY VMAT2 INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DYSKINESIA MARKET SIZE, BY ABLATIVE SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DYSKINESIA MARKET SIZE, BY ABLATIVE SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DYSKINESIA MARKET SIZE, BY DEEP BRAIN STIMULATION (DBS), BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DYSKINESIA MARKET SIZE, BY DEEP BRAIN STIMULATION (DBS), BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DYSKINESIA MARKET SIZE, BY ATHETOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DYSKINESIA MARKET SIZE, BY ATHETOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DYSKINESIA MARKET SIZE, BY CHOREA, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DYSKINESIA MARKET SIZE, BY CHOREA, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DYSKINESIA MARKET SIZE, BY DYSTONIA-RELATED DYSKINESIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DYSKINESIA MARKET SIZE, BY DYSTONIA-RELATED DYSKINESIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DYSKINESIA MARKET SIZE, BY MYOCLONIC DYSKINESIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DYSKINESIA MARKET SIZE, BY MYOCLONIC DYSKINESIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DYSKINESIA MARKET SIZE, BY PARKINSON’S DYSKINESIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DYSKINESIA MARKET SIZE, BY PARKINSON’S DYSKINESIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DYSKINESIA MARKET SIZE, BY SPASMODIC TORTICOLLIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DYSKINESIA MARKET SIZE, BY SPASMODIC TORTICOLLIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DYSKINESIA MARKET SIZE, BY TARDIVE DYSKINESIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DYSKINESIA MARKET SIZE, BY TARDIVE DYSKINESIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL DYSKINESIA MARKET SIZE, BY INTRAVENOUS (IV) & INFUSION-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL DYSKINESIA MARKET SIZE, BY INTRAVENOUS (IV) & INFUSION-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL DYSKINESIA MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL DYSKINESIA MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL DYSKINESIA MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL DYSKINESIA MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL DYSKINESIA MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL DYSKINESIA MARKET SIZE, BY TRANSDERMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL DYSKINESIA MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL DYSKINESIA MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL DYSKINESIA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL DYSKINESIA MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL DYSKINESIA MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL DYSKINESIA MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL DYSKINESIA MARKET SIZE, BY SPECIALTY CLINICS & REHABILITATION CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL DYSKINESIA MARKET SIZE, BY SPECIALTY CLINICS & REHABILITATION CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS DYSKINESIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS DYSKINESIA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES DYSKINESIA MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES DYSKINESIA MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 109. CANADA DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 110. CANADA DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 111. CANADA DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2018-2024 (USD MILLION)
TABLE 112. CANADA DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2025-2030 (USD MILLION)
TABLE 113. CANADA DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 114. CANADA DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 115. CANADA DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 116. CANADA DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 117. CANADA DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2018-2024 (USD MILLION)
TABLE 118. CANADA DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2025-2030 (USD MILLION)
TABLE 119. CANADA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 120. CANADA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 121. CANADA DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 122. CANADA DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 123. MEXICO DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 124. MEXICO DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 125. MEXICO DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2018-2024 (USD MILLION)
TABLE 126. MEXICO DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2025-2030 (USD MILLION)
TABLE 127. MEXICO DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 128. MEXICO DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 129. MEXICO DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 130. MEXICO DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 131. MEXICO DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2025-2030 (USD MILLION)
TABLE 133. MEXICO DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 134. MEXICO DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 135. MEXICO DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 136. MEXICO DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 195. GERMANY DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 196. GERMANY DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 197. GERMANY DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2018-2024 (USD MILLION)
TABLE 198. GERMANY DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2025-2030 (USD MILLION)
TABLE 199. GERMANY DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 200. GERMANY DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 201. GERMANY DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 202. GERMANY DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 203. GERMANY DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2018-2024 (USD MILLION)
TABLE 204. GERMANY DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2025-2030 (USD MILLION)
TABLE 205. GERMANY DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 206. GERMANY DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 207. GERMANY DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 208. GERMANY DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 209. FRANCE DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 210. FRANCE DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 211. FRANCE DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2018-2024 (USD MILLION)
TABLE 212. FRANCE DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2025-2030 (USD MILLION)
TABLE 213. FRANCE DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 214. FRANCE DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 215. FRANCE DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 216. FRANCE DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 217. FRANCE DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2018-2024 (USD MILLION)
TABLE 218. FRANCE DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2025-2030 (USD MILLION)
TABLE 219. FRANCE DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 220. FRANCE DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 221. FRANCE DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 222. FRANCE DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 223. RUSSIA DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 224. RUSSIA DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 225. RUSSIA DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2018-2024 (USD MILLION)
TABLE 226. RUSSIA DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2025-2030 (USD MILLION)
TABLE 227. RUSSIA DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 228. RUSSIA DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 229. RUSSIA DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 230. RUSSIA DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 237. ITALY DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 238. ITALY DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 239. ITALY DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2018-2024 (USD MILLION)
TABLE 240. ITALY DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2025-2030 (USD MILLION)
TABLE 241. ITALY DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 242. ITALY DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 243. ITALY DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 244. ITALY DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 245. ITALY DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2018-2024 (USD MILLION)
TABLE 246. ITALY DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2025-2030 (USD MILLION)
TABLE 247. ITALY DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 248. ITALY DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 249. ITALY DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 250. ITALY DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 251. SPAIN DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 252. SPAIN DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 253. SPAIN DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2018-2024 (USD MILLION)
TABLE 254. SPAIN DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2025-2030 (USD MILLION)
TABLE 255. SPAIN DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 256. SPAIN DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 257. SPAIN DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 258. SPAIN DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 259. SPAIN DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2018-2024 (USD MILLION)
TABLE 260. SPAIN DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2025-2030 (USD MILLION)
TABLE 261. SPAIN DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 262. SPAIN DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 263. SPAIN DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 264. SPAIN DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2018-2024 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2025-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2018-2024 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2025-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 280. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2018-2024 (USD MILLION)
TABLE 282. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2025-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 284. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 286. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2018-2024 (USD MILLION)
TABLE 288. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2025-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 292. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 294. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2018-2024 (USD MILLION)
TABLE 296. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2025-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 298. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 299. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 300. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 301. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2018-2024 (USD MILLION)
TABLE 302. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2025-2030 (USD MILLION)
TABLE 303. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 304. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 305. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 306. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 307. DENMARK DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 308. DENMARK DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 309. DENMARK DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2018-2024 (USD MILLION)
TABLE 310. DENMARK DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2025-2030 (USD MILLION)
TABLE 311. DENMARK DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 312. DENMARK DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 313. DENMARK DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 314. DENMARK DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 315. DENMARK DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2018-2024 (USD MILLION)
TABLE 316. DENMARK DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2025-2030 (USD MILLION)
TABLE 317. DENMARK DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 318. DENMARK DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 319. DENMARK DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 320. DENMARK DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 321. NETHERLANDS DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 322. NETHERLANDS DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 323. NETHERLANDS DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2018-2024 (USD MILLION)
TABLE 324. NETHERLANDS DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2025-2030 (USD MILLION)
TABLE 325. NETHERLANDS DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 326. NETHERLANDS DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 327. NETHERLANDS DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 328. NETHERLANDS DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 329. NETHERLANDS DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2018-2024 (USD MILLION)
TABLE 330. NETHERLANDS DYSKINESIA MARKET SIZE, BY DYSKINESIA TYPE, 2025-2030 (USD MILLION)
TABLE 331. NETHERLANDS DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 332. NETHERLANDS DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 333. NETHERLANDS DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 334. NETHERLANDS DYSKINESIA MARKET SIZE, BY PATIENT CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 335. QATAR DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 336. QATAR DYSKINESIA MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 337. QATAR DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2018-2024 (USD MILLION)
TABLE 338. QATAR DYSKINESIA MARKET SIZE, BY NON-PHARMACOLOGICAL APPROACHES, 2025-2030 (USD MILLION)
TABLE 339. QATAR DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 340. QATAR DYSKINESIA MARKET SIZE, BY PHARMACOLOGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 341. QATAR DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 342. QATAR DYSKINESIA MARKET SIZE, BY SURGICAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 343. QATAR DYSKINESIA MARKET SIZE, BY DYSKINESIA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Dyskinesia market report include:
  • Abbott Laboratories
  • AbbVie Inc.
  • Addex Therapeutics Ltd.
  • Bukwang Pharmaceutical Co., Ltd
  • Clearmind Medicine Inc.
  • Ipsen Pharma SAS
  • IRLAB Therapeutics AB
  • Luye Pharma Group Ltd.
  • Medtronic PLC
  • Melior Pharmaceuticals
  • Mitsubishi Tanabe Pharma Corporation
  • Motac France Sarl
  • Neurocrine Biosciences, Inc.
  • Neurolixis Inc.
  • PharmaTher Holdings Ltd.
  • Prilenia Therapeutics B.V.
  • ReCode Therapeutics, Inc.
  • Serina Therapeutics, Inc.
  • SOM INNOVATION BIOTECH, SA
  • Supernus Pharmaceuticals, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Toray Industries, Inc.
  • Vistagen Therapeutics, Inc.
  • Voyager Therapeutics, Inc.
  • Zydus Lifesciences Limited

Table Information

Report AttributeDetails
No. of Pages183
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.66 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.23 Billion
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Dyskinesia- Pipeline Insight, 2025 - Product Image

Dyskinesia- Pipeline Insight, 2025

  • Clinical Trials
  • 80 Pages
  • Global
From
Tardive Dyskinesia Therapeutics - Global Strategic Business Report - Product Image

Tardive Dyskinesia Therapeutics - Global Strategic Business Report

  • Report
  • 240 Pages
  • Global
From
Tardive Dyskinesia Market - A Global and Regional Analysis: Focus on Drug Class, Route of Administration, and Region - Analysis and Forecast, 2025-2035 - Product Image

Tardive Dyskinesia Market - A Global and Regional Analysis: Focus on Drug Class, Route of Administration, and Region - Analysis and Forecast, 2025-2035

  • Report
  • Global
From
Primary Ciliary Dyskinesia (PCD) - Pipeline Insight, 2025 - Product Image

Primary Ciliary Dyskinesia (PCD) - Pipeline Insight, 2025

  • Clinical Trials
  • 40 Pages
  • Global
From
Tardive Dyskinesia Therapeutics Global Market Report 2025 - Product Image

Tardive Dyskinesia Therapeutics Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From

About the Dyskinesia Market

Dyskinesia is a neurological disorder characterized by involuntary, repetitive movements. It is most commonly associated with the use of certain central nervous system drugs, such as antipsychotics and levodopa. Dyskinesia can cause a range of physical symptoms, including jerky movements, tremors, and difficulty with coordination. It can also lead to psychological symptoms, such as anxiety and depression. The dyskinesia market is composed of a range of pharmaceutical companies that produce drugs to treat the disorder. These companies develop and market medications that can reduce the severity of symptoms and improve quality of life. Many of these drugs are approved by the FDA and are available in both generic and brand-name forms. Some of the companies in the dyskinesia market include AbbVie, Allergan, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Teva Pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.